Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Verve Therapeutics, Inc. - Verve Therapeutics ( NASDAQ:VERV )

3 weeks ago

SAN DIEGO, Aug. 28, 2024 ( GLOBE NEWSWIRE ) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Verve Therapeutics, Inc. VERV securities between August 9, 2022 and April 1, 2024.

Ticker	Sentiment	Impact
VERV	Neutral	52 %